U.S. Markets closed
  • S&P 500

    3,783.28
    -7.65 (-0.20%)
     
  • Dow 30

    30,273.87
    -42.43 (-0.14%)
     
  • Nasdaq

    11,148.64
    -27.76 (-0.25%)
     
  • Russell 2000

    1,762.69
    -13.08 (-0.74%)
     
  • Crude Oil

    88.01
    +0.25 (+0.28%)
     
  • Gold

    1,725.50
    +4.70 (+0.27%)
     
  • Silver

    20.64
    +0.09 (+0.44%)
     
  • EUR/USD

    0.9897
    -0.0089 (-0.8907%)
     
  • 10-Yr Bond

    3.7590
    +0.1420 (+3.93%)
     
  • Vix

    28.55
    -0.52 (-1.79%)
     
  • GBP/USD

    1.1337
    -0.0138 (-1.1983%)
     
  • USD/JPY

    144.4790
    +0.2800 (+0.1942%)
     
  • BTC-USD

    20,155.49
    -148.54 (-0.73%)
     
  • CMC Crypto 200

    456.09
    -2.31 (-0.50%)
     
  • FTSE 100

    7,052.62
    -33.84 (-0.48%)
     
  • Nikkei 225

    27,120.53
    +128.33 (+0.48%)
     

Sanofi sees EU regulatory decision on its COVID booster in weeks

BRUSSELS, Sept 5 (Reuters) - The European Union's drugs regulator may be a few weeks from a decision to approve the experimental COVID-19 vaccine developed by French pharmaceutical company Sanofi and its British partner GSK, a Sanofi executive said on Monday.

Thomas Triomphe, Sanofi's executive vice-president for vaccines, told a hearing in the European Parliament that he believed the European Medicines Agency would decide on the possible approval of the vaccine in few weeks. (Reporting by Francesco Guarascio @fraguarascio; Editing by Jan Harvey)